Company Profile

The company is developing a system based on artificial intelligence technology. It built a biological process model based on measured data. It's capable of analyzing and predicting the functions of various kinds of compounds without prior knowledge and related properties of compounds in research and development drugs. It's also able to design and optimize novel small molecule drugs against particular diseases, predict drug toxicity and long-term adverse drug reactions. Predicted results can be directly verified in animal models, providing clinical trial drug candidates for drug development companies.

At present, this system has completed several studies on compound function prediction and experimentally validation. In the three research directions of lifespan extension, obesity, hyperuricemia, more than a dozen compounds have been verified in mice, and the overall prediction accuracy rate is about 60%.

News

R&D Direction

Hyperuricemia

Obesity

Longevity

Anti-Oxidation

Investors